Global Gastroesophageal Reflux Disease Therapeutics Market Size, Status and Forecast 2025

Publisher Name :
Date: 12-Jun-2018
No. of pages: 98
Inquire Before Buying

This report studies the global Gastroesophageal Reflux Disease Therapeutics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Gastroesophageal Reflux Disease Therapeutics market by companies, region, type and end-use industry.

In 2017, the global Gastroesophageal Reflux Disease Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered

AstraZeneca

Eisai

Takeda Pharmaceutical

GlaxoSmithKline

Johnson & Johnson

Daewoong Pharmaceutical

Ironwood Pharmaceuticals

Rottapharm Madaus

Peer Medical

Reviva Pharmaceuticals

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Market segment by Type, the product can be split into

Antacids

H2 Receptor Blockers

Proton Pump Inhibitors (PPIs)

Pro-kinetic Agents

Others

Market segment by Application, split into

Hospital Pharmacy

Drug Stores

General Stores

Supermarkets

The study objectives of this report are:

To study and forecast the market size of Gastroesophageal Reflux Disease Therapeutics in global market.

To analyze the global key players, SWOT analysis, value and global market share for top players.

To define, describe and forecast the market by type, end use and region.

To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Gastroesophageal Reflux Disease Therapeutics are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Gastroesophageal Reflux Disease Therapeutics Manufacturers

Gastroesophageal Reflux Disease Therapeutics Distributors/Traders/Wholesalers

Gastroesophageal Reflux Disease Therapeutics Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Gastroesophageal Reflux Disease Therapeutics market, by end-use.

Detailed analysis and profiles of additional market players.

Global Gastroesophageal Reflux Disease Therapeutics Market Size, Status and Forecast 2025

Table of Contents
Global Gastroesophageal Reflux Disease Therapeutics Market Size, Status and Forecast 2025
1 Industry Overview of Gastroesophageal Reflux Disease Therapeutics
1.1 Gastroesophageal Reflux Disease Therapeutics Market Overview
1.1.1 Gastroesophageal Reflux Disease Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Gastroesophageal Reflux Disease Therapeutics Market by Type
1.3.1 Antacids
1.3.2 H2 Receptor Blockers
1.3.3 Proton Pump Inhibitors (PPIs)
1.3.4 Pro-kinetic Agents
1.3.5 Others
1.4 Gastroesophageal Reflux Disease Therapeutics Market by End Users/Application
1.4.1 Hospital Pharmacy
1.4.2 Drug Stores
1.4.3 General Stores
1.4.4 Supermarkets
2 Global Gastroesophageal Reflux Disease Therapeutics Competition Analysis by Players
2.1 Gastroesophageal Reflux Disease Therapeutics Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 AstraZeneca
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.2 Eisai
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.3 Takeda Pharmaceutical
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.4 GlaxoSmithKline
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.5 Johnson & Johnson
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.6 Daewoong Pharmaceutical
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.7 Ironwood Pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.8 Rottapharm Madaus
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.9 Peer Medical
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.10 Reviva Pharmaceuticals
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
4 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type and Application (2013-2018)
4.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2013-2018)
4.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
4.3 Potential Application of Gastroesophageal Reflux Disease Therapeutics in Future
4.4 Top Consumer/End Users of Gastroesophageal Reflux Disease Therapeutics
5 United States Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
5.1 United States Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
5.2 United States Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
5.3 United States Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
6 Europe Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
6.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
6.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
6.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
7 China Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
7.1 China Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
7.2 China Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
7.3 China Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
8 Japan Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
8.1 Japan Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
8.2 Japan Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
8.3 Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
9 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
9.1 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
9.2 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
10 India Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
10.1 India Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
10.2 India Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
10.3 India Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size (Value) by Regions (2018-2025)
11.1.1 United States Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.1.2 Europe Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.1.3 China Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.1.4 Japan Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.1.5 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.1.6 India Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size (Value) by Type (2018-2025)
11.3 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2018-2025)
12 Gastroesophageal Reflux Disease Therapeutics Market Dynamics
12.1 Gastroesophageal Reflux Disease Therapeutics Market Opportunities
12.2 Gastroesophageal Reflux Disease Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Gastroesophageal Reflux Disease Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Gastroesophageal Reflux Disease Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions (2013-2018)
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type in 2017
Figure Antacids Market Size (Million USD) and Growth Rate (2013-2018)
Figure H2 Receptor Blockers Market Size (Million USD) and Growth Rate (2013-2018)
Figure Proton Pump Inhibitors (PPIs) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Pro-kinetic Agents Market Size (Million USD) and Growth Rate (2013-2018)
Figure Others Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Share by Application in 2017
Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in Hospital Pharmacy (2013-2018)
Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in Drug Stores (2013-2018)
Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in General Stores (2013-2018)
Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in Supermarkets (2013-2018)
Table Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table AstraZeneca Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of AstraZeneca (2013-2018)
Figure AstraZeneca Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Eisai Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Eisai (2013-2018)
Figure Eisai Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Takeda Pharmaceutical Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Takeda Pharmaceutical (2013-2018)
Figure Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
Figure Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Daewoong Pharmaceutical Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Daewoong Pharmaceutical (2013-2018)
Figure Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Ironwood Pharmaceuticals Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Ironwood Pharmaceuticals (2013-2018)
Figure Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Rottapharm Madaus Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Rottapharm Madaus (2013-2018)
Figure Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Peer Medical Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Peer Medical (2013-2018)
Figure Peer Medical Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Reviva Pharmaceuticals Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Reviva Pharmaceuticals (2013-2018)
Figure Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Product (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Product (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Share by Product in 2017
Table Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Gastroesophageal Reflux Disease Therapeutics
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table United States Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure United States Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table China Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table China Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure China Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table India Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table India Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure India Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size and Growth Rate (2018-2025)
Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Regions (2018-2025)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share (2018-2025)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Regions in 2025
Figure United States Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Type (2018-2025)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Type in 2018
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Type in 2025
Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Application (2018-2025)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Application in 2018
  • Global Gene Delivery System Market Size, Status and Forecast 2018-2025
    Published: 18-Sep-2018        Price: US 3900 Onwards        Pages: 98
    This report focuses on the global Gene Delivery System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Delivery System development in United States, Europe and China. Gene delivery systems are used to deliver therapeutic drugs targeting a specific area. Gene delivery is a procedure that introduces foreign DNA into host cells. In 2017, the global Gene Delivery System market size was xx million US$ and it i......
  • Global Deaf Aid Market Insights, Forecast to 2025
    Published: 18-Sep-2018        Price: US 4900 Onwards        Pages: 114
    This report studies the global market size of Deaf Aid in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Deaf Aid in these regions. This research report categorizes the global Deaf Aid market by top players/brands, region, type and end user. This report also studies the global Deaf Aid market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and chall......
  • 2018-2023 Global Contrast Media (Contrast Agents) Consumption Market Report
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 136
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Contrast Media (Contrast Agents) market for 2018-2023. Contrast media (or contrast agents) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast me......
  • 2018-2023 Global Closed System Drug Transfer Device (CSTD) Consumption Market Report
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 132
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Closed System Drug Transfer Device (CSTD) market for 2018-2023. Closed System Drug Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors int......
  • 2018-2023 Global Auto-Injectors Consumption Market Report
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 158
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Auto-Injectors market for 2018-2023. Auto-injector is a medical device designed to deliver a dose of a particular drug. Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug load......
  • 2018-2023 Global Viral Vectors and Plasmid DNA Manufacturing Market Report (Status and Outlook)
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 131
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Viral Vectors and Plasmid DNA Manufacturing market for 2018-2023. The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases. Based on classification, the proportion of Viral Vectors Manufacturing in 2016 is about 79.74%, with revenue about 200 M USD. Based on application, Cancers......
  • Global Transcatheter Heart Valves Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 117
    The sales volume of transcatheter heart valves is increasing across several healthcare centers due to the growing prevalence of various heart diseases such as cardio valvular diseases, mitral regurgitation, and aortic stenosis require valve replacement. Scope of the Report: This report focuses on the Transcatheter Heart Valves in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the m......
  • Global Transcatheter Aortic Valve Replacement Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 119
    Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. Whereas, the TAVR procedures can be done through very small openings ......
  • Global Tracheostomy Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 121
    A tracheostomy is a surgically created passageway through the front of the neck and into the trachea (windpipe). A tube is inserted through the hole and enable the patient breathing. This allows air to go to lungs, avoiding nose, mouth and throat and remove the secretions from the lungs. In rare cases, tracheostomy is permanent but the hole should be blocked when tracheostomy is no longer needed. This surgical procedure has several complications such as bleeding, permanent damage in vocal cord, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs